Skip to main content
Journal of Patient-Reported Outcomes

Table 9 Comparison of FACT-GOG-Ntx and FACT-GOG-Ntx-4 by Clinically-Reported CIPN by Time 3

From: Performance of the FACT-GOG-Ntx to assess chemotherapy-induced peripheral neuropathy (CIPN) in pediatric high risk Hodgkin lymphoma: report from the Children’s Oncology Group AHOD 1331 study

Mean (SD), n

No CIPN by Time 3

CIPN by Time 3

P-value

FACT-GOG-Ntx

   

 Youth

39.34 (5.25), n = 197

32.98 (9.19), n = 57

 < 0.001

 Parent-Proxy

39.26 (5.92), n = 189

32.80 (10.52), n = 52

 < 0.001

FACT-GOG-Ntx-4

   

 Youth

14.21 (2.60), n = 197

10.86 (4.48), n = 57

 < 0.001

 Parent-Proxy

14.24 (2.88), n = 189

10.88 (4.89), n = 52

 < 0.001

  1. FACT-GOG-Ntx scores can range from 0 to 44 with higher scores indicating better functioning
  2. FACT-GOG-Ntx-4 scores can range from 0 to 16 with higher scores indicating better functioning
  3. Youth report is for patients aged 11–21.9 years; parent-proxy report is for youth aged 5–17.9 years
Back to article page